Clinical characteristics of all subjects
| . | Diabetic . | Nondiabetic . |
|---|---|---|
| n | 140 | 108 |
| Age (years) | 61.1 ± 10.2 | 54.1 ± 14.6* |
| Sex (male/female) | 75/65 | 52/56 |
| BMI (kg/m2) | 25.1 ± 0.4 | 26.1 ± 0.57 |
| L/S ratio | 1.090 ± 0.020 | 1.006 ± 0.028† |
| VFA (cm2) | 124 ± 6.23 | 117 ± 5.87 |
| SFA (cm2) | 178 ± 8.58 | 192 ± 10.1 |
| Ferritin (ng/ml) | 167.3 ± 13.6 | 188.9 ± 18.2 |
| Glucose (mg/dl) | 148.5 ± 4.87 | 105.2 ± 1.43* |
| Insulin (μU/ml) | 8.93 ± 0.745 | 9.34 ± 0.746 |
| HOMA-IR | 3.10 ± 0.225 | 2.10 ± 0.113† |
| A1C (%) | 7.51 ± 0.122 | 5.09 ± 0.39* |
| C-reactive protein (mg/dl) | 0.097 ± 0.009 | 0.101 ± 0.011 |
| AST (IU/l) | 27.4 ± 1.47 | 23.6 ± 2.41* |
| ALT (IU/l) | 34.3 ± 2.41 | 51.9 ± 4.59* |
| Smoking (%) | 26.4 | 12.6 |
| . | Diabetic . | Nondiabetic . |
|---|---|---|
| n | 140 | 108 |
| Age (years) | 61.1 ± 10.2 | 54.1 ± 14.6* |
| Sex (male/female) | 75/65 | 52/56 |
| BMI (kg/m2) | 25.1 ± 0.4 | 26.1 ± 0.57 |
| L/S ratio | 1.090 ± 0.020 | 1.006 ± 0.028† |
| VFA (cm2) | 124 ± 6.23 | 117 ± 5.87 |
| SFA (cm2) | 178 ± 8.58 | 192 ± 10.1 |
| Ferritin (ng/ml) | 167.3 ± 13.6 | 188.9 ± 18.2 |
| Glucose (mg/dl) | 148.5 ± 4.87 | 105.2 ± 1.43* |
| Insulin (μU/ml) | 8.93 ± 0.745 | 9.34 ± 0.746 |
| HOMA-IR | 3.10 ± 0.225 | 2.10 ± 0.113† |
| A1C (%) | 7.51 ± 0.122 | 5.09 ± 0.39* |
| C-reactive protein (mg/dl) | 0.097 ± 0.009 | 0.101 ± 0.011 |
| AST (IU/l) | 27.4 ± 1.47 | 23.6 ± 2.41* |
| ALT (IU/l) | 34.3 ± 2.41 | 51.9 ± 4.59* |
| Smoking (%) | 26.4 | 12.6 |
Data are means ± SE.
P < 0.01 diabetic vs. nondiabetic;
P < 0.05. ALT, alanine aminotransferase; AST, aspartate aminotransferase.